The 2nd International Forum of Pharmaceutical Inspectorates will be held in the UAE on 24–25 November 2025
On 24 November, the 2nd International Forum of Pharmaceutical Inspectorates will commence its work in the United Arab Emirates. This year, the Forum will bring together experts and representatives of regulatory authorities from more than 50 countries.
The Forum will unite leading specialists in Good Manufacturing Practice (GMP) to discuss priority areas of global pharmaceutical regulation.
The IFPI programme includes a high-level plenary session with the participation of heads of regulatory authorities from Russia, Indonesia, Jordan, Belarus, and Cuba, as well as panel discussions dedicated to current issues of GMP regulation. In particular, experience exchange is planned on the harmonization of regulatory requirements for medicinal product manufacturing and on approaches to the mutual recognition of GMP inspection outcomes. Mechanisms for the inspection of biological medicinal products, as well as issues related to ensuring the availability of modern medicines in the healthcare systems of different countries, will also be addressed.
The Russian Federation is represented at the Forum by Dmitry Galkin, Head of the Russian GMP Inspectorate and Director of the Department for the Development of the Pharmaceutical and Medical Industry of the Ministry of Industry and Trade of the Russian Federation, and by Vladislav Shestakov, Director of the State Institute of Drugs and Good Practices. For the second consecutive year, Russia serves as Co-Chair of the Organizing Committee of the event.
Key discussion topics:
- Harmonization of medicinal product manufacturing regulation: development trends within regional unions and progress toward unified quality standards.
- Availability of modern medicinal products: various models for providing populations in different countries with innovative therapies.
- Regulatory reliance and recognition of GMP inspection outcomes: evaluation of the equivalence of regulatory systems and mechanisms of mutual recognition.
- Inspection of biological medicinal products: specific approaches to quality control and information exchange on biopharmaceuticals.
“Cooperation among regulatory authorities leads to increased availability of high-quality, safe, and effective medicinal products and, at the same time, to greater transparency of regulatory mechanisms. The implementation of joint projects, the strengthening of professional trust, and participation in common expert platforms form the foundation that will help ensure patient safety both in Russia and across the world,”
emphasized Vladislav Shestakov, Director of the State Institute of Drugs and Good Practices.
He also noted:
“Quality is not a matter of inspections and reports. What matters is interaction with industry and collective work in a shared direction. I always say that the quality of products begins with the quality of thinking of their creators. This is our shared responsibility, and just like in classical music, achieving a pure sound requires professional instruments and fine tuning.”
The participation of the Ministry of Industry and Trade of Russia and the State Institute of Drugs and Good Practices in the 2nd International Forum of Pharmaceutical Inspectorates represents another step in Russia’s integration into the global GMP community. The Forum is regarded as an important platform for shaping a unified global agenda in Good Manufacturing Practice, strengthening professional trust, and coordinating regulatory initiatives. Russia’s activities in international pharmaceutical regulation are aimed at consolidating efforts to enhance the quality and safety of medicinal products, which aligns with the strategic priorities of state policy in the healthcare and industrial sectors.
“The world unites for patient safety” — this is the motto of this year’s Forum, reflecting the shared mission of participants to ensure the availability of high-quality medicinal products for patients in all countries.
More detailed information on the programme and registration is available on the official Forum website:
https://ifpi-forum.com/
Other materials
- BIOPROM: The results of the work of “SID & GP” and the NCSO were presented to First Deputy Prime Minister Denis Manturov
- Results of the X All-Russian GMP Conference with International Participation Summarized
- X GMP Conference Discusses Convergence of Regulatory Practices within the EAEU
- Moscow Hosts the X GMP Conference Under the Motto “Regulating Today — Creating a Stable Tomorrow”
- 10th All-Russian GMP Conference with International Participation Launches Off in Moscow